CVS Health denies coverage for breakthrough HIV drug, committing 'clear violation' of ACA
CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."
August 22, 2025
CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
clinical trial
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.
September 13, 2024
Puberty Blockers Will be Limited to Clinical Trials, Says U.K. Health Service
LGBTQ+ activists in the U.K. are criticizing this restriction on care for transgender youth.
June 11, 2023
Meet a Stem Cell Patient on the Front Lines for Finding an HIV Cure
In an exclusive clip from Ending Disease, Andrew shares how he hopes his participation in a clinical trial could change the world.
November 23, 2020